24800 Federal Register / Vol. 61, No. 96 / Thursday, May 16, 1996 / Notices

Respondents No. of respondents

No. of responses/respondentAvg. burden/

response

(in hrs)

Primary Contact ................................................................................................................................ 50 12 1

Pharmacist ........................................................................................................................................ 50 60 1.8

Microbiologist .................................................................................................................................... 50 60 0.35

Total ....................................................................................................................................... ...................... ...................... ........................

The total burden hours is 7050. Send

comments to Desk Officer, CDC; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503.

4. National Nosocomial Infections

Surveillance (NNIS) System—(0920–

0012)—Extension—The National

Nosocomial Infections Surveillance

(NNIS) system is currently the only

source for national data on nosocomial

(hospital-associated) infections in the

United States. It first began collecting

data in 1970. It is a collaborative project

between the Hospital Infections Program

of the Centers for Disease Control and

Prevention (CDC) and voluntarily

participating hospitals in the United

States. The goals of the system are to: (1)

develop comparative nosocomial

infection rates that can be used by

hospitals to assess quality of care, (2)

describe the scope and magnitude,

including trends, of the nosocomial

infection problem in the U.S., (3)

identify risk factors associated with

these infections, (4) assist hospitals in

the effective use of surveillance data to

improve the quality of patient care, and

(5) conduct collaborative research

studies. Data are collected using

protocols developed by CDC that define

the specific populations of patients at

risk, risk factors, and outcomes. The

decision about which component(s) to

use is made by each hospital depending

on its own needs for surveillance data.

The data are collected by trained

surveillance personnel, assisted by

hospital personnel, and are entered into

IDEAS, a surveillance software which

makes the data available for analysis at

the hospital’s convenience. The data are

currently transmitted to CDC by floppy

disk, then aggregated into a national

database. During 1996, it will become

possible for some hospitals to transmit

the data to CDC through the NNIS

telecommunications system. This

system is expected to be used by all

participating hospitals by 1997,

resulting in reduced response time.

NNIS methodology, which has been

published, is the standard nosocomial

infection surveillance methodology and

is used at least in part by most U.S.

hospitals.

Respondents No. of respondents

No. of responses/respondentAvg. burden/

response (in

hours)

Hospitals ............................................................................................................................................. 251 12 0.16

The total burden hours is 481. Send

comments to Desk Officer, CDC; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503.

Dated: May 10, 1996.

[FR Doc. 96–12329 Filed 5–15–96; 8:45 am]

BILLING CODE 4163–18–P

[Announcement Number 631]

National Institute for Occupational

Safety and Health; Research and

Demonstration Grants

Introduction

The National Institute for

Occupational Safety and Health

(NIOSH) of the Centers for Disease

Control and Prevention (CDC) is

soliciting grant applications for research

and demonstration projects related to

occupational safety and health (see the

section ‘‘Availability of Funds’’).

CDC is committed to achieving the

health promotion and disease

prevention objectives of ‘‘Healthy

People 2000,’’ a national activity to

reduce morbidity and mortality and

improve the quality of life. This

announcement is related to the priority

area of Occupational Safety and Health.

(For ordering a copy of ‘‘Healthy People

2000,’’ see the section ‘‘Where to Obtain

Additional Information’’.)

Authority

This program is authorized under the

Public Health Service Act, as amended,

Section 301 (42 U.S.C. 241); the

Occupational Safety and Health Act of

1970, Section 20(a) (29 U.S.C. 669); and

the Federal Mine Safety and Health

Amendments Act of 1977, as amended,

Section 501 (30 U.S.C. 951). The

applicable program regulations are in 42

CFR Part 52.

Eligible Applicants

Eligible applicants include domestic

and foreign non-profit and for-profit

organizations, universities, colleges,

research institutions, and other public

and private organizations, including

State and local governments and small,

minority and/or woman-owned

businesses. Exceptions: Applicants for

the Special Emphasis Research Career

Award (SERCA) Grant and Small Grant

programs must be citizens or persons

lawfully admitted to the United States

for permanent residence (resident alien)

at the time of application and must be

employed by a domestic institution.

Smoke-Free Workplace

CDC strongly encourages all grant

recipients to provide a smoke-free

workplace and to promote the non-use

of all tobacco products, and Public Law

103–227, the Pro-Children Act of 1994,

prohibits smoking in certain facilities

that receive federal funds and in which

education, library, day care, health care,

and early childhood development

services are provided to children.

Availability of Funds

For fiscal year (FY) 1996, the budget

is projected to be $10,000,000. Of that

amount, $7,000,000 is committed to

support 47 non-competing continuing

awards. Therefore, $3,000,000 is

available for new and competing

renewal awards. The overall budget

includes $400,000 for Small Business

Innovation Research grant awards, of

which $237,000 is already committed to

a non-competing continuation award. In

addition, this overall budget includes

funds for a special emphasis on

construction health and safety research.
Federal Register / Vol. 61, No. 96 / Thursday, May 16, 1996 / Notices 24801

Grant applications should be focused

on the research priorities described in

the section ‘‘Funding Priorities’’ that

includes new research priorities

developed in a process which resulted

in defining a National Occupational

Research Agenda. Grant proposals in

these areas will compete for the

available funds as noted in the previous

paragraph, as well as for funds

announced through Requests for

Applications that are anticipated in FY

1996 and FY 1997.

Purpose

The purpose of this grant program is

to develop knowledge that can be used

in preventing occupational diseases and

injuries. Thus, NIOSH will support the

following types of applied research

projects: Causal research to identify and

investigate the relationships between

hazardous working conditions and

associated occupational diseases and

injuries; methods research to develop

more sensitive means of evaluating

hazards at work sites, as well as

methods for measuring early markers of

adverse health effects and injuries;

control research to develop new

protective equipment, engineering

control technology, and work practices

to reduce the risks of occupational

hazards; and demonstrations to evaluate

the technical feasibility or application of

a new or improved occupational safety

and health procedure, method,

technique, or system.

Mechanisms of Support

Applications responding to this

announcement will be reviewed by staff

for their responsiveness to the following

program requirements. Grants are

funded for 12- month budget periods in

project periods up to five years for

research project grants and

demonstration project grants; three

years for SERCA grants; and two years

for small grants. Continuation awards

within the project period are made on

the basis of satisfactory progress and on

the availability of funds. The types of

grants NIOSH supports are as follow:

1. Research Project Grants (R01)

A research project grant application

should be designed to establish,

discover, develop, elucidate, or confirm

information relating to occupational

safety and health, including innovative

methods, techniques, and approaches

for dealing with problems. These

studies may generate information that is

readily available to solve problems or

contribute to a better understanding of

the causes of work-related diseases and

injuries.

2. Demonstration Project Grants (R18)

A demonstration project grant

application should address, either on a

pilot or full-scale basis, the technical or

economic feasibility of implementing a

new/improved innovative procedure,

method, technique, or system for

preventing occupational safety or health

problems. The project should be

conducted in an actual workplace where

a baseline measure of the problem will

be defined, the new/improved approach

will be implemented, a follow-up

measure of the problem will be

documented, and an evaluation of the

benefits will be conducted.

3. Special Emphasis Research Career

Award (SERCA) Grants (K01)

The SERCA grant is intended to

provide opportunities for individuals to

acquire experience and skills essential

to the study of work-related hazards,

and in so doing, create a pool of highly

qualified investigators who can make

future contributions to research in the

area of occupational safety and health.

SERCA grants are not intended for

individuals without research

experience, or for productive,

independent investigators with a

significant number of publications and

of senior academic rank. Moreover, the

award is not intended to substitute one

source of salary support for another for

an individual who is already conducting

full-time research; nor is it intended to

be a mechanism for providing

institutional support.

Candidates must: (1) Hold a doctoral

degree; (2) have research experience at

or above the doctoral level; (3) not be

above the rank of associate professor; (4)

be employed at a domestic institution;

and (5) be citizens or persons lawfully

admitted to the United States for

permanent residence (resident alien) at

the time of application.

This non-renewable award provides

support for a three-year period for

individuals engaged in full-time

research and related activities. Awards

will not exceed $50,000 per year in

direct costs for salary support (plus

fringe benefits), technical assistance,

equipment, supplies, consultant costs,

domestic travel, publications, and other

costs. The indirect cost rate applied is

limited to 8 percent of the direct costs,

excluding tuition and related fees and

equipment expenses, or to the actual

indirect cost rate, whichever results in

the lesser amount.

A minimum of 60 percent time must

be committed to the proposed research

project, although full-time is desirable.

Other work in the area of occupational

safety and health will enhance the

candidate’s qualifications but is not a

substitute for this requirement. Related

activities may include research career

development activities as well as

involvement in patient care to the extent

that it will strengthen research skills.

Fundamental/basic research will not be

supported unless the project will make

an original contribution for applied

technical knowledge in the

identification, evaluation, or control of

occupational safety and health hazards

(e.g., development of a diagnostic

technique for early detection of an

occupational disease). Research project

proposals must be of the applicants’

own design and of such scope that

independent investigative capability

will be evident within three years. At

the completion of this three-year award,

it is intended that awardees should be

better able to compete for individual

research project grants awarded by

NIOSH.

SERCA grant applications should be

identified as such on the application

form. Section 2 of the application (the

Research Plan) should include a

statement regarding the applicant’s

career plans and how the proposed

research will contribute to a career in

occupational safety and health research.

This section should also include a letter

of recommendation from the proposed

advisor(s).

4. Small Grants (R03)

The small grant program is intended

to stimulate proposals from individuals

who are considering a research career in

occupational safety and health; as such,

the minimum time commitment is 10%.

It is expected that a recipient would

subsequently compete for a career

development grant (K01) or for a

traditional research project grant (R01)

related to occupational safety and

health. The award is not intended to

supplement ongoing or other proposed

research; nor is it intended to be a

mechanism for providing institutional

support. Please note that fundamental/

basic research is generally not

supported.

The small grant investigators must be

United States citizens or persons

lawfully admitted to the United States

for permanent residence (resident alien)

at the time of application who are

predoctoral students, post-doctoral

researchers (within 3 years following

completion of doctoral degree or

completion of residency or public

health training), or junior faculty

members (no higher than assistant

professor). If university policy requires

that a more senior person be listed as

principal investigator, it should be clear

in the application which person is the
24802 Federal Register / Vol. 61, No. 96 / Thursday, May 16, 1996 / Notices

small grant investigator. Except for

applicants who are assistant professors,

there must be one or more named

mentors to assist with the project. A

biographical sketch is required for the

small grant investigator, as well as for

the supervisor and other key

consultants, as appropriate.

This non-renewable award provides

support for project periods of up to two

years to carry out exploratory or pilot

studies, to develop or test new

techniques or methods, or to analyze

data previously collected. Awards will

not exceed $25,000 per year in direct

costs for salary support (plus fringe

benefits), technical assistance,

equipment, supplies, consultant costs,

domestic travel, publications, and other

costs. The indirect costs will be based

upon the negotiated indirect cost rate of

the applicant organization. An

individual may not receive more than

two small grant awards, and then, only

if the awards are at different stages of

development (e.g., doctoral student,

post-doctoral researcher, or junior

faculty member).

Funding Priorities

The NIOSH program priorities, listed

below, are applicable to all of the above

types of grants listed under the section

‘‘Mechanisms of Support.’’ These

priority areas were developed by NIOSH

and its partners in the public and

private sectors to provide a framework

to guide occupational safety and health

research in the next decade—not only

for NIOSH but also for the entire

occupational safety and health

community. Approximately 500

organizations and individuals outside

NIOSH provided input into the

development of the National

Occupational Research Agenda (NORA).

This attempt to guide and coordinate

research nationally is responsive to a

broadly perceived need to address

systematically those topics that are most

pressing and most likely to yield gains

to the worker and the nation. Fiscal

constraints on occupational safety and

health research are increasing, making

even more compelling the need for a

coordinated and focused research

agenda. NIOSH intends to support

projects that facilitate progress in

understanding and preventing adverse

effects among workers. The conditions

or examples listed under each category

are selected examples, not

comprehensive definitions of the

category. Investigators may also apply in

other areas related to occupational

safety and health, but the rationale for

the significance of the research to the

field of occupational safety and health

must be presented in the grant

application.

The Agenda identifies 21 research

priorities. These priorities reflect a

remarkable degree of concurrence

among a large number of stakeholders.

The NORA priority research areas are

grouped into three categories: Disease

and Injury, Work Environment and

Workforce, and Research Tools and

Approaches. The NORA document is

available through the NIOSH Home

Page; http://www.cdc.gov/niosh/

nora.html.

NORA Priority Research Areas

Disease and Injury

Allergic and Irritant Dermatitis

Asthma and Chronic Obstructive Pulmonary

Disease

Fertility and Pregnancy Abnormalities

Hearing Loss

Infectious Diseases

Low Back Disorders

Musculoskeletal Disorders of the Upper

Extremities

Traumatic Injuries

Work Environment and Workforce

Emerging Technologies

Indoor Environment

Mixed Exposures

Organization of Work

Special Populations at Risk

Research Tools and Approaches

Cancer Research Methods

Control Technology and Personal Protective

Equipment

Exposure Assessment Methods

Health Services Research

Intervention Effectiveness Research

Risk Assessment Methods

Social and Economic Consequences of

Workplace Illness and Injury

Surveillance Research Methods

Potential applicants with questions

concerning the acceptability of their

proposed work are strongly encouraged

to contact the ‘‘Technical Information

Contact,’’ Dr. Roy M. Fleming, listed in

this announcement under the section

‘‘Where to Obtain Additional

Information.’’

Applications Submission and Deadlines

and Review Dates

The research grant application Form

PHS–398 (OMB Number 0925–0001) is

to be used in applying for these grants.

These forms are available at most

institutional offices of sponsored

research; from the Extramural Outreach

and Information Resources Office,

Office of Extramural Research, 6701

Rockledge Drive, MS–C7910, Bethesda,

MD 20892–7910, telephone (301) 435–

0714; fax (301) 480–8443; Internet

girg@drgpo.drg.nih.gov; and from the

contacts listed under the section

‘‘Where to Obtain Additional

Information.’’

The original and five copies of the

PHS–398 must be submitted to Division

of Research Grants, National Institutes

of Health, Suite 1040, 6701 Rockledge

Drive, MS–C7710, Bethesda, MD 20892–

7710, on or before the specified receipt

dates provided below. A mailing label is

provided in the Form PHS–398

application package.

The timetable for receiving

applications and awarding grants is

given below. This is a continuous

announcement, consequently, these

receipt dates will be on-going until

further notice.

RESEARCH AND DEMONSTRATION

PROJECT GRANTS

Receipt

date *

Initial review

Secondary reviewEarliest

possible

date

February

1.

June/July September.December 1.

June 1 ... Oct/Nov January April 1.

October 1 Feb/Mar May ....... August 1.

*Deadlines for competing continuation applications or revised applications are 1 month

later.

SERCA AND SMALL GRANTS

Receipt

date

Initial review

Secondary reviewEarliest

possible

date

March 1 June/July August ... November 1.

July 1 ..... Oct/Nov December.March 1.

November 1.Feb/Mar April ....... July 1.

Applications must be received by the

above receipt dates. To prevent

problems caused by carrier delays,

retain a legible proof-of-mailing receipt

from the carrier, dated no later than one

week prior to the receipt date. If the

receipt date falls on a weekend, it will

be extended to Monday; if the date falls

on a holiday, it will be extended to the

following work day. The receipt date

will be waived only in extenuating

circumstances. To request such a

waiver, include an explanatory letter

with the signed, completed application.

No request for a waiver will be

considered prior to receipt of the

application.

Evaluation Criteria

Applications will be assigned on the

basis of established referral guidelines.

Applications will be reviewed for

scientific and technical merit by study

sections of the Division of Research

Grants, NIH, in accordance with the

standard NIH peer review procedures.

Following scientific technical review,
Federal Register / Vol. 61, No. 96 / Thursday, May 16, 1996 / Notices 24803

the applications will receive a secondlevel programmatic review by NIOSH.

Notification of the review

recommendations will be sent to the

applicants after the initial review.

Awards will be made based on results

of the initial and secondary reviews, as

well as availability of funds.

Applications that are complete and

responsive to the program

announcement will be evaluated for

scientific merit by an appropriate peer

review group. As part of the initial merit

review, all applications will receive a

written critique and undergo a process

in which only those applications

deemed to have the highest scientific

merit, generally the top half of

applications under review, will be

discussed, assigned a priority score, and

receive a second level review by the

Institute programmatic review

committee.

1. The initial (peer) review is based on

scientific merit and significance of the

project, competence of the proposed

staff in relation to the type of research

involved, feasibility of the project,

likelihood of its producing meaningful

results, appropriateness of the proposed

project period, adequacy of the

applicant’s resources available for the

project, and appropriateness of the

budget request.

Demonstration grant applications will

be reviewed additionally on the basis of

the following criteria:

• Degree to which project objectives

are clearly established, obtainable, and

for which progress toward attainment

can and will be measured.

• Availability, adequacy, and

competence of personnel, facilities, and

other resources needed to carry out the

project.

• Degree to which the project can be

expected to yield or demonstrate results

that will be useful and desirable on a

national or regional basis.

• Documentation of cooperation from

industry, unions, or other participants

in the project, where applicable.

SERCA grant applications will be

reviewed additionally on the basis of

the following criteria:

• The review process will consider

the applicant’s scientific achievements,

the applicant’s research career plan in

occupational safety and health, and the

degree to which the applicant’s

institution offers a superior research

environment (supportive nature,

including letter(s) of reference from

advisor(s) which should accompany the

application).

Consideration will be given to the fact

that the applicants for small grants do

not have extensive experience with the

grants process.

2. In the secondary review, the

following factors will be considered:

• The results of the initial review.

• The significance of the proposed

study to the mission of NIOSH.

(1) Relevance to occupational safety

and health by contributing to

achievement of research objectives

specified in Section 20(a) of the

Occupational Safety and Health Act of

1970 and Section 501 of the Federal

Mine Safety and Health Amendments

Act of 1977,

(2) Magnitude of the problem in terms

of numbers of workers affected,

(3) Severity of the disease or injury in

the worker population,

(4) Potential contribution to applied

technical knowledge in the

identification, evaluation, or control of

occupational safety and health hazards,

(5) Program balance, and

(6) Policy and budgetary

considerations.

Questions regarding the above criteria

should be addressed to the

Programmatic Technical Information

Contact listed under ‘‘Where to Obtain

Additional Information.’’

Executive Order 12372 Review

Applications are not subject to review

as governed by Executive Order 12372,

Intergovernmental Review of Federal

Programs.

Catalog of Federal Domestic Assistance

Number

The Catalog of Federal Domestic

Assistance number is 93.262.

Public Health System Reporting

Requirements

This program is not subject to the

Public Health System Reporting

Requirements.

Other Requirements

Human Subjects

If the proposed project involves

research on human subjects, the

applicant must comply with the

Department of Health and Human

Services Regulations (45 CFR Part 46)

regarding the protection of human

subjects. Assurance must be provided to

demonstrate that the project will be

subject to initial and continuing review

by an appropriate institutional review

committee. The applicant will be

responsible for providing assurance in

accordance with the appropriate

guidelines and forms provided in the

application kit.

Women and Racial and Ethnic

Minorities

It is the policy of the Centers for

Disease Control and Prevention (CDC) to

ensure that women and racial and

ethnic groups will be included in CDC/

ATSDR-supported research projects

involving human subjects, whenever

feasible and appropriate. Racial and

ethnic groups are those defined in OMB

Directive No. 15 and include American

Indian, Alaska Native, Asian, Pacific

Islander, Black and Hispanic.

Applicants shall ensure that women and

racial and ethnic minority populations

are appropriately represented in

applications for research involving

human subjects. Where clear and

compelling rationale exist that inclusion

is inappropriate or not feasible, this

situation must be explained as part of

the application. In conducting review

for scientific merit, review groups will

evaluate proposed plans for inclusion of

minorities and both sexes as part of the

scientific assessment and scoring. This

policy does not apply to research

studies when the investigator cannot

control the race, ethnicity and/or sex of

subjects. Further guidance to this policy

is contained in the Federal Register,

Vol. 60, No. 179, pages 47947–47951,

and dated Friday, September 15, 1995.

Where To Obtain Additional

Information

To receive additional written

information, call (404) 332–4561. You

will be asked your name, address, and

phone number and will need to refer to

Announcement 631. In addition, this

announcement is also available through

the CDC Home Page on the Internet. The

address for the CDC Home Page is http:/

/www.cdc.gov. You will receive a

complete program description,

information on application procedures,

and application forms. If you have

questions after reviewing the contents of

all the documents, business

management technical assistance may

be obtained from Georgia Jang, Grants

Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., MS–E13,

Atlanta, GA 30305, telephone (404)

842–6796; fax 404–842–6513; Internet

glj2@opspgo1.em.cdc.gov. Programmatic

technical assistance may be obtained

from Roy M. Fleming, Sc.D., Associate

Director for Grants, National Institute

for Occupational Safety and Health,

Centers for Disease Control and

Prevention (CDC), 1600 Clifton Road,

NE., Building 1, Room 3053, MS-D30,

Atlanta, GA 30333, telephone (404)

639–3343; fax (404) 639–4616; Internet

rmf2@niood1.em.cdc.gov.

Please Refer to Announcement

Number 631 When Requesting
24804 Federal Register / Vol. 61, No. 96 / Thursday, May 16, 1996 / Notices

Information and Submitting an

Application.

Potential applicants may obtain a

copy of ‘‘Healthy People 2000’’ (Full

Report, Stock No. 017–001–00474–0) or

‘‘Healthy People 2000’’ (Summary

Report, Stock No. 017–001–00473–1)

through the Superintendent of

Documents, Government Printing

Office, Washington, DC 20402–9325,

telephone (202) 512–1800.

Dated: May 8, 1996.

Diane D. Porter,

Acting Director, National Institute for

Occupational Safety and Health, Centers for

Disease Control and Prevention (CDC).

[FR Doc. 96–12253 Filed 5–15–96; 8:45 am]

BILLING CODE 4163–19–P

Advisory Committee on Immunization

Practices: Announcement of Meeting

and Request for Comments on Draft

Poliomyelitis Statement

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

Name: Advisory Committee on

Immunization Practices (ACIP).

Times and Dates: 8:30 a.m.–6 p.m., June

19, 1996. 8:30 a.m.–2:45 p.m., June 20, 1996.

Place: CDC, Auditorium B, Building 2,

1600 Clifton Road, NE, Atlanta, Georgia

30333.

Status: Open to the public, limited only by

the space available.

Purpose: The Committee is charged with

advising the Director, CDC, on the

appropriate uses of immunizing agents.

Matters to be Discussed: The Committee

will discuss, among other items, the revision

of the ACIP recommendation on

poliomyelitis. Because of the considerable

interest in the revised ACIP recommendation

on poliomyelitis, there will be a public

comment period on the morning of June 19,

not to exceed three hours, during which

members of the public will be able to address

the ACIP members and executive staff of the

CDC on the draft ACIP poliomyelitis

prevention statement. This statement

introduces a sequential schedule of

inactivated poliovirus vaccine (IPV) followed

by oral poliovirus vaccine (OPV) and

includes the options of using any of three

schedules: OPV alone, IPV alone or the

sequential IPV—OPV schedule.

Other topics to be discussed at the meeting

include: measles, mumps, rubella (MMR)

policy statement; MMR vaccination of HIVinfected persons; a draft statement on

acellular pertussis vaccine; the use of single

antigen tetanus toxoid; a draft statement for

rabies post-exposure treatment; an

immunization update on varicella vaccine; a

draft statement on reminder/recall systems;

and achieving consistency among policy

statements and vaccine package inserts.

Other matters of relevance among the

Committee’s objectives may be discussed.

Agenda items are subject to change as

priorities dictate.

Copies of the revised draft ACIP

recommendation, ‘‘Poliomyelitis Prevention

in the United States: Introduction of A

Sequential Schedule of Inactivated Poliovirus

Vaccine (IPV) Followed by Oral Poliovirus

Vaccine (OPV),’’ are available to the public

by notifying the contact person. Copies may

be sent electronically upon request.

Anyone wishing to make an oral

presentation should submit their request, in

writing, to the contact person by close of

business June 3, 1996. The request should

include the name, address, and telephone

number of the participant; the approximate

time needed; and a copy of the presentation

or a brief summary of the topic to be

presented. Depending on the number of

requests, up to six minutes will be allowed

for each oral presentation. Anyone wishing to

submit for consideration written comments

regarding the revised ACIP recommendation

on poliomyelitis prevention should submit

the written comments to the contact person

by June 13, 1996.

Contact Person for More Information:

Gloria A. Kovach, Committee Management

Specialist, CDC (16–4346), 1600 Clifton

Road, NE, M/S D50, Atlanta, Georgia 30333,

Telephone 404/639–7250.

Dated: May 10, 1996.

Nacny C. Hirsch,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 96–12256 Filed 5–15–96; 8:45 am]

BILLING CODE 4163–18–M

Health Care Financing Administration

[HCFA–287]

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, has submitted to the

Office of Management and Budget

(OMB) the following proposal for the

collection of information. Interested

persons are invited to send comments

regarding the burden estimate or any

other aspect of this collection of

information, including any of the

following subjects: (1) The necessity and

utility of the proposed information

collection for the proper performance of

the agency’s functions; (2) the accuracy

of the estimated burden; (3) ways to

enhance the quality, utility, and clarity

of the information to be collected; and

(4) the use of automated collection

techniques or other forms of information

technology to minimize the information

collection burden.

Type of Information Collection

Request: Extension of a currently

approved collection; Title of

Information Collection: Home Office

Cost Statement; Form No.: HCFA 287;

Use: Medicare law permits components

of chain organizations to be reimbursed

for certain costs incurred by the chain

home offices. The Home Office Cost

Statement is required by the fiscal

intermediary to verify Home Office

Costs claimed by the components.

Frequency: Annually; Affected Public:

Business or other for-profit, and Not-forprofit institutions; Number of

Respondents: 1,231; Total Annual

Responses: 1,231; Total Annual Hours

Requested: 573,646.

To request copies of the proposed

paperwork collections referenced above,

E-mail your request, including your

address, to Paperwork@hcfa.gov, or call

the Reports Clearance Office on (410)

786–1326. Written comments and

recommendations for the proposed

information collections should be sent

within 30 days of this notice directly to

the OMB Desk Officer designated at the

following address: OMB Human

Resources and Housing Branch,

Attention: Allison Eydt, New Executive

Office Building, Room 10235,

Washington, D.C. 20503.

Dated: May 9, 1996.

Kathleen B. Larson,

Director, Management Planning and Analysis

Staff, Office of Financial and Human

Resources, Health Care Financing

Administration.

[FR Doc. 96–12318 Filed 5–15–96; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF THE INTERIOR

Bureau of Land Management

[WO–350–1430–01]

Information Collection Submitted to

the Office of Management and Budget

for Review Under the Paperwork

Reduction Act

The proposal for the collection of

information listed below has been

submitted to the Office of Management

and Budget for approval under the

provisions of the Paperwork Reduction

Act (44 U.S.C. Chapter 35). Copies of the

proposed collection of information and

related forms may be obtained by

contacting the Bureau’s Clearance

Officer at the phone number listed

below. Comments and suggestions on

the proposal should be made directly to

the Bureau Clearance Officer and to the